← Back to Search

Focused Ultrasound

Transcranial ExABlate for Brain Tumor

N/A
Waitlist Available
Research Sponsored by InSightec
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at the time of exablate transcranial procedure
Awards & highlights

Study Summary

This trial is testing if it is safe to increase the amount of a chemotherapy drug that enters the brain by using ultrasound waves to open the blood-brain-barrier for a short period of time.

Eligible Conditions
  • Brain Tumor

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at the time of exablate transcranial procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and at the time of exablate transcranial procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Device and Procedure related adverse events
Secondary outcome measures
Severity of Device and Procedure related adverse events

Trial Design

1Treatment groups
Experimental Treatment
Group I: Transcranial ExAblateExperimental Treatment1 Intervention
MR Guided Focused Ultrasound

Find a Location

Who is running the clinical trial?

InSightecLead Sponsor
89 Previous Clinical Trials
3,704 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~1 spots leftby Apr 2025